Financials
- Market Capitalization 4.34 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-9.81
Fiyat/satışlar oranı
781.65
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1321 | CRSP CRISPR Therapeutics AG - Common Shares | 50.10 USD | -2.81% | -5.47% | -4.70% | -28.48% | 4.84 B USD | ||
| 1357 | DFTX Definium Therapeutics, Inc. - Common Shares | 34.38 USD | -2.33% | -2.72% | -14.50% | +127.53% | 4.62 B USD | ||
| 1455 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.28 USD | -1.13% | -4.06% | +1.94% | +46.47% | 4.03 B USD | ||
| 1473 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 36.28 USD | -5.64% | -8.52% | -18.82% | +138.21% | 3.94 B USD |